Clinical Trials Directory

Trials / Completed

CompletedNCT01571804

Pregabalin Reduce the Sevoflurane Requirement

Does Pregabalin Reduce the Sevoflurane Requirement During Laparoscopic Cholecystectomy? Mansoura University Hospitals Experience.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
Male
Age
25 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Preoperative administration of pregabalin would reduce the end tidal concentration of sevoflurane during laparoscopic cholecystectomy with added beneficial improving of the quality of postoperative analgesia.

Detailed description

laparoscopic cholecystectomy is a painful and stressful surgical procedure. Pregabalin is a lipophilic structural analogue of the inhibitory γ-aminobutyric acid by binding to the presynaptic voltage-gated calcium channels that are widely distributed throughout the central and peripheral nervous system. Pregabalin has anticonvulsant, anxiolytic, sleep-modulating, anti-hyperalgesic, opioid-sparing6 and anti-allodynic properties through inhibition of the release of excitatory neurotransmitters such as glutamate, norepinephrine, serotonin, dopamine and substance P. These unique characteristics make pregabalin as a useful therapeutic for treating neuropathic pain and acute postoperative pain in several models of incisional injury and inflammatory conditions including laparoscopic cholecystectomy.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboto receive two identical placebo capsules 1 hr before surgery
DRUGpregabalinone capsule of pregabalin 150 mg and one placebo capsule 1 hr before surgery
DRUGpregabalintwo capsules of pregabalin 150 mg 1 hr before surgery

Timeline

Start date
2011-12-01
Primary completion
2012-02-01
Completion
2012-03-01
First posted
2012-04-05
Last updated
2012-05-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT01571804. Inclusion in this directory is not an endorsement.